July 12th, 2019 | Pharmacy Pearls

This edition of Pharmacy Pearls reviews the available epinephrine injector options for the treatment of anaphylaxis. There are several devices available (both brand and generic), and the cost to patients can vary greatly. In addition to information regarding differences in the devices and an update on the nationwide shortage of brand EpiPen, the take away…

Read More ›

June 24th, 2019 | Pharmacy Pearls

This edition of Pharmacy Pearls highlights the availability of several generic maintenance inhalers now on the market and how to ensure patients get the least expensive formulation at the pharmacy. The goal is to increase patient access to these inhalers, so we encourage the use of the generics whenever possible and Symbicort when the generics…

Read More ›

May 9th, 2019 | NewsPharmacy Pearls

One of the 2019 AHP Pharmacy Team targets is to limit the use of Nasonex for allergic rhinitis given the availability of equally effective and far less expensive OTC products, such as fluticasone propionate. Given that allergy season is upon us, this Pharmacy Pearls presents a primer to the treatment of allergic rhinitis with information…

Read More ›

March 12th, 2019 | NewsPharmacy Pearls

This month, we are releasing an AHP quality improvement initiative for ADHD in patients ≤21 years of age. Recognizing that ADHD is complicated in terms of diagnosis, the impact of comorbidities, and multiple available treatment options, we have chosen to initially focus on rates of pediatric ADHD diagnosis and network-wide prescribing patterns of stimulant medications…

Read More ›

February 19th, 2019 | Clinical ConnectionsPharmacy Pearls

The AHP Pharmacy Task Force works to identify opportunities that will enhance the quality, safety and value of medication treatment for our patients. Recently, we identified a cohort of patients across the PCN on duplicate therapy for Type 2 Diabetes with a GLP-1 agonist (e.g., Victoza, Trulicity, Byetta, Bydureon) and a DPP-4 inhibitor (e.g., Januvia,…

Read More ›

January 11th, 2019 | NewsPharmacy Pearls

This edition of Pharmacy Pearls reviews the new drug baloxavir (Xofluza) and its role in therapy compared to other oral antiviral agents for the treatment of influenza based on currently published data and CDC treatment recommendations.

November 13th, 2018 | NewsPharmacy Pearls

As a reminder, November 12-18, 2018 is U.S. Antibiotic Awareness Week. The CDC is urging healthcare professionals to prescribe antibiotics only when necessary to help fight antibiotic resistance and protect patients from adverse events. During U.S. Antibiotic Awareness Week the CDC promotes Be Antibiotics Aware, an educational effort to raise awareness about the importance of…

Read More ›

September 25th, 2018 | Pharmacy Pearls

This edition of Pharmacy Pearls reviews the available basal insulin products with regards to cost and side effects to consider when selecting an agent for a patient. Additionally, we have included guidance for switching between insulin products and review recently published literature that shows that NPH insulin is noninferior to basal insulin analogs. Finally, we…

Read More ›

August 2nd, 2018 | Clinical ConnectionsPharmacy Pearls

Starting at the end of August, AHP’s clinical pharmacists will be offering on-site provider visits to provide up-to-date, objective evidence focusing on outpatient medication management topics. These visits are: • Typically 10-15 minutes, based on providers’ schedules • 1:1 or in group provider settings, whichever is more convenient • Intended to be interactive- the clinical…

Read More ›

July 20th, 2018 | Pharmacy Pearls

This edition of Pharmacy Pearls discusses some of the nuances associated with selecting a urinary antispasmodic for incontinence, including a brief comparison of safety, tolerability, and approximate cost. Additionally, we are featuring a new section of Pharmacy Pearls called “Clinical Pharmacist Medication Management Highlight.” This will be a section where we gather examples from clinical…

Read More ›